Latest Insider Transactions at Dexcom Inc (DXCM)
This section provides a real-time view of insider transactions for Dexcom Inc (DXCM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DEXCOM INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DEXCOM INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,624
-1.84%
|
$367,360
$140.38 P/Share
|
|
Mar 25
2024
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
4,137
-5.14%
|
$579,180
$140.0 P/Share
|
|
Mar 15
2024
|
Matthew Vincent Dolan EVP, Strategy & Corporate Dev |
SELL
Open market or private sale
|
Direct |
4,203
-2.97%
|
$546,390
$130.45 P/Share
|
|
Mar 12
2024
|
Matthew Vincent Dolan EVP, Strategy & Corporate Dev |
SELL
Open market or private sale
|
Direct |
6,710
-12.14%
|
$899,140
$134.41 P/Share
|
|
Mar 12
2024
|
Teri L Lawver EVP Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,764
-6.67%
|
$638,376
$134.41 P/Share
|
|
Mar 12
2024
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
7,736
-2.82%
|
-
|
|
Mar 12
2024
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14,639
-5.07%
|
$1,961,626
$134.41 P/Share
|
|
Mar 12
2024
|
Kevin R Sayer Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
81,007
-4.23%
|
$10,773,931
$133.19 P/Share
|
|
Mar 12
2024
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
20,321
-3.61%
|
$2,682,372
$132.67 P/Share
|
|
Mar 12
2024
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
11,661
-12.0%
|
$1,562,574
$134.41 P/Share
|
|
Mar 12
2024
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,799
-10.98%
|
$1,179,066
$134.41 P/Share
|
|
Mar 08
2024
|
Michael Jon Brown EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,711
+21.32%
|
-
|
|
Mar 08
2024
|
Matthew Vincent Dolan EVP, Strategy & Corporate Dev |
BUY
Grant, award, or other acquisition
|
Direct |
21,711
+28.2%
|
-
|
|
Mar 08
2024
|
Teri L Lawver EVP Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,053
+26.73%
|
-
|
|
Mar 08
2024
|
Jacob Steven Leach EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,053
+8.28%
|
-
|
|
Mar 08
2024
|
Kevin R Sayer Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
51,692
+11.09%
|
-
|
|
Mar 08
2024
|
Sadie Stern EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,711
+17.73%
|
-
|
|
Mar 08
2024
|
Jereme M Sylvain EVP, Chief Financal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,053
+21.14%
|
-
|
|
Feb 20
2024
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
3,363
-4.51%
|
$390,108
$116.73 P/Share
|
|
Jan 16
2024
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
2,734
-3.54%
|
$336,282
$123.63 P/Share
|
|
Jan 16
2024
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,902
-3.54%
|
$356,946
$123.63 P/Share
|
|
Jan 16
2024
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,978
-1.49%
|
$489,294
$123.63 P/Share
|
|
Jan 16
2024
|
Kevin R Sayer Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
37,325
-9.33%
|
$4,590,975
$123.63 P/Share
|
|
Jan 16
2024
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
1,568
-1.44%
|
$191,296
$122.61 P/Share
|
|
Jan 12
2024
|
Jereme M Sylvain EVP, Chief Financal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,171
+8.5%
|
-
|
|
Jan 12
2024
|
Sadie Stern EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,620
+8.51%
|
-
|
|
Jan 12
2024
|
Jacob Steven Leach EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,697
+3.51%
|
-
|
|
Jan 12
2024
|
Kevin R Sayer Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
72,709
+15.38%
|
-
|
|
Dec 18
2023
|
Barry J. Regan EVP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,675
-2.79%
|
$202,675
$121.85 P/Share
|
|
Dec 18
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,932
-4.02%
|
$354,772
$121.85 P/Share
|
|
Dec 18
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,675
-2.2%
|
$202,675
$121.85 P/Share
|
|
Dec 18
2023
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,932
-1.13%
|
$354,772
$121.85 P/Share
|
|
Dec 18
2023
|
Paul R Flynn EVP Global Revenue |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,163
-6.07%
|
$382,723
$121.85 P/Share
|
|
Dec 15
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
2,000
-3.53%
|
$244,000
$122.77 P/Share
|
|
Dec 15
2023
|
Nicholas Augustinos Director |
SELL
Open market or private sale
|
Indirect |
3,976
-10.46%
|
$489,048
$123.02 P/Share
|
|
Dec 12
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
3,000
-5.03%
|
$360,000
$120.0 P/Share
|
|
Dec 11
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
392
-0.51%
|
$45,864
$117.66 P/Share
|
|
Dec 01
2023
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,612
-1.98%
|
$411,768
$114.5 P/Share
|
|
Nov 24
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
411
-0.33%
|
$45,210
$110.8 P/Share
|
|
Nov 22
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,176
-1.52%
|
$129,360
$110.0 P/Share
|
|
Nov 19
2023
|
Barry J. Regan EVP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,106
-6.39%
|
$427,024
$104.06 P/Share
|
|
Nov 19
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,106
-5.03%
|
$427,024
$104.06 P/Share
|
|
Nov 15
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
1,000
-1.65%
|
$101,000
$101.26 P/Share
|
|
Nov 09
2023
|
Girish Naganathan EVP Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,725
-5.4%
|
$253,425
$93.27 P/Share
|
|
Nov 08
2023
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
2,019
-3.05%
|
$191,805
$95.22 P/Share
|
|
Oct 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
411
-0.33%
|
$34,935
$85.75 P/Share
|
|
Oct 16
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
1,000
-1.62%
|
$77,000
$77.58 P/Share
|
|
Sep 22
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
411
-0.33%
|
$36,168
$88.4 P/Share
|
|
Sep 15
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
1,000
-1.59%
|
$101,000
$101.5 P/Share
|
|
Sep 12
2023
|
Bridgette P Heller Director |
SELL
Open market or private sale
|
Direct |
600
-2.47%
|
$63,600
$106.56 P/Share
|